Nature Index |
Featured
-
-
News |
Geneticists pan paper that claims to predict a person's face from their DNA
Reviewers and a co-author of a paper by genomics entrepreneur Craig Venter claim that it misrepresents the risks of public access to genome data.
- Sara Reardon
-
News |
NIH research grants yield economic windfall
More than 30% of biomedical studies funded by the US government are later cited in commercial patents.
- Elie Dolgin
-
News |
Broad Institute wins bitter battle over CRISPR patents
The US Patent and Trademark Office issues a verdict in legal tussle over rights to genome-editing technology.
- Heidi Ledford
-
News |
Why the CRISPR patent verdict isn’t the end of the story
From legal challenges to ongoing experimentation, the story of who owns the rights to CRISPR–Cas9 gene editing is still being written.
- Heidi Ledford
-
News |
CRISPR heavyweights battle in US patent court
The University of California, Berkeley, and the Broad Institute are vying for lucrative rights to the gene-editing system.
- Sara Reardon
-
News |
Spats, sniping and science: the rows behind the Nobels
The latest crop of prize predictions illuminates the century-long struggle to assign credit to individual researchers.
- Heidi Ledford
-
News |
Titanic clash over CRISPR patents turns ugly
Accusations of impropriety feature in escalating dispute.
- Heidi Ledford
-
News |
Europe proposes copyright reform to help scientists mine research papers
Long-awaited plan would exempt computer-aided harvesting from EU copyright law.
- Declan Butler
-
News |
US personalized-medicine industry takes hit from Supreme Court
Recent decisions seem to drive spike in patent rejections.
- Heidi Ledford
-
-
News |
‘Open-hardware’ pioneers push for low-cost lab kit
Conference aims to raise awareness of shared resources for building lab equipment.
- Elizabeth Gibney
-
News |
How the US CRISPR patent probe will play out
Decision could determine who profits from the gene-editing technique in future.
- Heidi Ledford
-
Correspondence |
Edited plants should not be patented
- John R. Porter
- , Jean-Louis Durand
- & Taline Elmayan
-
News |
Bitter fight over CRISPR patent heats up
Unusual battle among academic institutions holds key to gene-editing tool’s future use.
- Heidi Ledford
-
Outlook |
Research: Biology's big hit
Scientists now have several tools to edit the genomes of living organisms. One of the most recent is revolutionizing research and has thrust two of its creators into the limelight.
- Zoë Corbyn
-
Editorial |
Built on trust
Written agreements between parties in research collaborations are not a sign of a lack of faith.
-
-
News |
US ‘export rules’ threaten research
Proposed updates to national-security regulations would restrict collaboration with foreign scientists and industry.
- Alexandra Witze
-
Editorial |
A patent problem
Making lawsuits more risky for patent trolls is just one way to stop abuse of the system.
-
News |
Congress seeks to quash patent trolls
Revised legislation would spare universities from being penalized in the same way as unscrupulous companies.
- Heidi Ledford
-
Outlook |
Research impact: A tale of two systems
Tensions between the old communist regime and modern market forces are hindering efforts to turn China's scientific discoveries into commercial advances.
- Peng Tian
-
-
News |
China’s patent boom brings legal wrangles
Court decision sets precedent for protecting intellectual property.
- David Cyranoski
-
Comment |
Make nanotechnology research open-source
To drive innovation at the nanoscale, the patent thicket must be chopped down, argues Joshua M. Pearce.
- Joshua M. Pearce
-
News |
Single-patent legislation hits another roadblock
Parliament postpones vote over revisions to reform agreement.
- Daniel Cressey
-
News |
Cancelled project spurs debate over geoengineering patents
SPICE research consortium decides not to field-test its technology to reflect the Sun’s rays.
- Daniel Cressey
-
News |
Geoengineering experiment cancelled amid patent row
Balloon-based ‘test bed’ for climate-change mitigation abandoned.
- Daniel Cressey
-
News |
Novartis challenges India's patent law
Drug company up for rematch against clause prohibiting indefinite extension of patents.
- Priya Shetty
-
News |
US Supreme Court upends diagnostics patents
Industry warns ruling may stifle innovation in personalized medicine.
- Heidi Ledford
-
News |
Researchers aim to chart intellectual trends in arXiv
'Culturomics' team pivots from Google Books to scientific preprints.
- Eric Hand
-
News |
Climate deal leaves questions on green fund and tech transfer
Little progress made on fund to help countries cope with climate change.
- T.V. Padma
- , Busani Bafana
- & Linda Nordling
-
News |
German science organizations slam European court over stem-cell ruling
European Court of Justice had no right to impose moral judgement on science, says influential group.
- Alison Abbott
-
News |
India pushes for tech transfer at Durban climate talks
Environment minister says that sharing intellectual property is vital for tackling global warming.
- T. V. Padma
-
News |
European ban on stem-cell patents has a silver lining
Researchers can work without fear of action over patent infringement.
- Ewen Callaway
-
News |
European court bans patents based on embryonic stem cells
Final decision could stifle investment in developing therapies.
- Ewen Callaway
-
News |
'Patent trolls' target biotechnology firms
Opportunistic patent litigation threatens the life sciences.
- Erika Check Hayden
-
Career Brief |
Single patent system
Universal system would help ease researcher mobility, says white paper.
-
Editorial |
Patent medicine
A simplification of the US patent system is good news for inventors, but could have gone further.
-
News |
Human-rights shift under fire
Critics concerned by scientific bodies' move away from traditional campaigning on behalf of oppressed researchers.
- Declan Butler
-
News |
Charities seek cut of drug royalties
Non-profits that support medical research are angling for a share of the proceeds and intellectual-property rights.
- Heidi Ledford
-
-
-
News |
US legislation aims to simplify rules for inventors
Bill aims to reduce costly lawsuits by changing how rights to innovations are awarded.
- Eugenie Samuel Reich
-
News |
Patent dispute threatens US Alzheimer's research
Lawsuit could expose hundreds of scientists to property-rights litigation.
- Erika Check Hayden
-
News |
Europe rules against stem-cell patents
Work with human embryonic stem cells is 'contrary to ethics'.
- Alison Abbott
-
News |
European Court of Justice rejects stem-cell patents
Researchers surprised by judge's conservative stance.
- Alison Abbott
-
-
Comment |
More for the research dollar
Funders and universities should make the products of research more available — even if today's researchers pay a price, say Jeffrey L. Furman, Fiona Murray and Scott Stern.
- Jeffrey L. Furman
- , Fiona Murray
- & Scott Stern
-
News |
US government wants limits on gene patents
Unexpected challenge to controversial patents on naturally occurring DNA sequences.
- Heidi Ledford